Health News Archive - February 05, 2010
MANNEDORF, Switzerland and OXFORD, England, Feb.
LONDON and PALO ALTO, Calif., Feb. 5 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) today announced that Philip Haworth, Ph.D., chief executive officer, will deliver a corporate overview and business update at the 12th Annual BIO CEO & Investor Conference.
MELVILLE, N.Y., Feb.
PORT-AU-PRINCE, Haiti, Feb. 5 /PRNewswire/ -- Haiti telecom operator Voila has been busy since the January 12 earthquake providing local and international service to over a million Haitian customers and thousands of incoming relief workers.
VILLA GUARDIA, Italy, Feb. 5 /PRNewswire-FirstCall/ -- Gentium S.p.A.
SOUTH SAN FRANCISCO, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M.
INDIANAPOLIS, Feb. 5 /PRNewswire-FirstCall/ -- Arcadia Resources, Inc.
CRANBURY, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that its Board of Directors has elected John F. Crowley as Chairman of the Board in addition to his current role as Chief Executive Officer (CEO), effective immediately. Mr.
MELVILLE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- Henry Schein, Inc.
ROCKVILLE, Md., Feb. 5 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr.